Patents by Inventor Joseph John Temenak

Joseph John Temenak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Serotype and dengue group specific flurogenic probe based PCR (TaqMan) assays against the respective C and NS5 genomic and 3? non-coding regions of dengue virus
    Patent number: 7052878
    Abstract: Five fluorogenic probe hydrolysis reverse transcriptase-polymerase chain reaction (RT-PCR) (TaqMan™) assays are described for serotype-specific detection of dengue 1–4 and group-specific detection of dengue viruses. Type- and group-specific oligonucleotide primers and fluorogenic probes were designed against conserved regions of the dengue genome. The invention provides TaqMan PCR assays, which are rapid, sensitive, and specific screening and serotyping tools for the epidemiological study of dengue infections.
    Type: Grant
    Filed: September 29, 2004
    Date of Patent: May 30, 2006
    Assignee: The United States of America as represented by the Secretary of the Navy
    Inventors: Johnny Dale Callahan, Joseph John Temenak
  • Serotype and dengue group specific flurogenic probe based PCR (TaqMan) assays against the respective C and NS5 genomic and 3? non-coding regions of dengue virus
    Patent number: 6855521
    Abstract: Five fluorogenic probe hydrolysis reverse transcriptase-polymerase chain reaction (RT-PCR) (TaqMan™) assays are described for serotype-specific detection of dengue 1-4 and group-specific detection of dengue viruses. Type- and group-specific oligonucleotide primers and fluorogenic probes were designed against conserved regions of the dengue genome. The invention provides TaqMan PCR assays, which are rapid, sensitive, and specific screening and serotyping tools for the epidemiological study of dengue infections.
    Type: Grant
    Filed: December 1, 2000
    Date of Patent: February 15, 2005
    Assignee: The United States of America as represented by the Secretary of the Navy
    Inventors: Johnny Dale Callahan, Joseph John Temenak
  • Serotype and dengue group specific flurogenic probe based PCR (TaqMan) assays against the respective C and NS5 genomic and 3' non-coding regions of dengue virus
    Publication number: 20040126387
    Abstract: Five fluorogenic probe hydrolysis reverse transcriptase-polymerase chain reaction (RT-PCR) (TaqMan™) assays are described for serotype-specific detection of dengue 1-4 and group-specific detection of dengue viruses. Type- and group-specific oligonucleotide primers and fluorogenic probes were designed against conserved regions of the dengue genome. The invention provides TaqMan PCR assays, which are rapid, sensitive, and specific screening and serotyping tools for the epidemiological study of dengue infections.
    Type: Application
    Filed: December 1, 2000
    Publication date: July 1, 2004
    Inventors: Johnny Dale Callahan, Joseph John Temenak